Skip to main content

A hollow comb applicator to topically deliver drug to prevent alopecia in human cancer therapy patients

Project Overview

Human cancer patients receiving a 30-day course of radiotherapy for head and neck cancer must have solvent containing drug applied topically to their scalps to prevent alopecia. This is done using a hollow comb applicator that applies a specific amount of solvent to a specific area of the scalp. The client desires a device that will accurately dispense the drug and have a professional appearance so that it complies with the Institutional Review Board (IRB) standards for use in clinical trials.

Team Picture

Comb Applicator Team. Left to right: Rachel O'Connell. Jeff Theisen, Vanessa Grosskopf, Sam Paulsen.
Comb Applicator Team. Left to right: Rachel O'Connell. Jeff Theisen, Vanessa Grosskopf, Sam Paulsen.

Files

Contact Information

Team Members

  • Vanessa Grosskopf - Team Leader
  • Jeffrey Theisen - Communicator
  • Samantha Paulsen - BSAC
  • Rachel O'Connell - BWIG

Advisor and Client

  • Prof. John Webster - Advisor
  • Dr. Bill Fahl - Client
Back to Top